GLYCOSYLATION OF GLYCOPROTEIN HORMONE FREE SUBUNIT DURING PREGNANCY: DEVELOPMENT
妊娠期间糖蛋白无激素亚基的糖基化:发育
基本信息
- 批准号:6123246
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-07-01 至 1999-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
. The glycoprotein hormone a subunit is common to the
heterodi-ineric hormones CG,LH, FSH, and TSH. However, in its free
form, it is an important placental and pituitary product and has been
shown to have functions that are independent of the dimeric hormones.
Glycosylation of free cc differs fi7om glycosylation of the combined
form. The combination of cc and0 for heterodimer formation takes
place in the ER prior to processing of the immature glycans. In cc
subunits that have not combined with a 0 subunit, enzymes from the
post-translational glycosylation machinery have access to substrate
sites that are normally protected by the0 subunit of the heterodimer.
As a result, the free form of oc subunit generally contains more
elaborate oligosaccharide branching, as well as higher amounts of core
fucosylation than a subunit obtained from dissociated hormone. These
characteristic glycosylation patterns prevent secreted free (x
subunits from combining with 0 subunits that might be encountered
extracellularly, thus ensuring a population of free (x molecules. The
(x subunit is a major placental product and its glycosylation was
found to change dramatically during the advancement of pregnancy. In
this collaboration, we have analyzed the glycosylation changes in five
normal pregnancies. ESI NIS studies have indicated higher
core-fucosylation, as well as changes in branching of glycans. The
glycans were also determined by high-pH anion-exchange chromatography
and CID MS/N4S. Amounts of core-fucosylation and of triantennary
glycans increased substantially from early to late second trimester,
and a shift was observed from 1-4/1-3 toward predom~inantly
1-6/1-6-branched triantennary structures. The glycosylation changes
occurred in all individuals examined at the same gestational period,
suggesting developmental regulation of
N-acetylglucosaminyl-transferases IV and V, and a 6-fucosyltransferase
during normal pregnancy. These enzymatic activities also appear to be
affected in malignant transformation of the trophoblast. The findings
have important implications for the proposed use of specific forms of
glycosylation as markers for cancer, as the relative amounts of these
glycans in normal pregnancy will be determined by gestational age.
. 糖蛋白激素a亚单位是共同的,
异源二系激素CG、LH、FSH和TSH。 然而,在其自由
形式,它是一个重要的胎盘和垂体产品,
显示其功能不依赖于二聚体激素。
游离CC的糖基化不同于组合CC的糖基化。
form. 用于异二聚体形成的cc和0的组合需要
在处理未成熟聚糖之前将其置于ER中。 连铸
未与0亚基结合的亚基,
翻译后糖基化机制可接近底物
通常被异二聚体的0亚基保护的位点。
因此,α亚基的游离形式通常含有更多的
精细的寡糖分支,以及更高量的核心
岩藻糖基化比从解离的激素获得的亚基。 这些
特征性糖基化模式阻止分泌游离(x
子单元与可能遇到的0个子单元组合
细胞外,从而确保游离β分子的群体。 的
(x亚基是胎盘的主要产物,其糖基化是
在怀孕的过程中发生了巨大的变化。 在
通过这项合作,我们分析了五种糖基化的变化,
正常怀孕 ESI NIS研究表明,
核心岩藻糖基化以及聚糖分支的变化。 的
还通过高pH阴离子交换色谱法测定聚糖
和CID MS/N4S。 核心岩藻糖基化和三触角
聚糖从早期到晚期中期妊娠显著增加,
从1-4/1-3向优势转化
1-6/1-6分支三触角结构。 糖基化改变
发生在同一妊娠期检查的所有个体中,
这表明,
N-乙酰葡糖胺基转移酶IV和V,以及6-岩藻糖基转移酶
在正常怀孕期间。 这些酶活性似乎也是
在滋养层的恶性转化中受到影响。 这些发现
对拟议使用的特定形式的
糖基化作为癌症的标志物,作为这些糖基化的相对量,
正常妊娠中的聚糖将通过胎龄来确定。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DIANA L BLITHE其他文献
DIANA L BLITHE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DIANA L BLITHE', 18)}}的其他基金
GLYCOPROTEIN HORMONES: OLIGOSACCHARIDE STRUCTURE & FUNCTION
糖蛋白激素:低聚糖结构
- 批准号:
6254127 - 财政年份:1997
- 资助金额:
-- - 项目类别:
GLYCOPROTEIN HORMONES: OLIGOSACCHARIDE STRUCT & FUNCT: PREGNANCY RELATED HORMONE
糖蛋白激素:低聚糖结构
- 批准号:
5225901 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
REU Site: University of Colorado, Engineering Smart Biomaterials
REU 站点:科罗拉多大学,工程智能生物材料
- 批准号:
2348856 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
An iPSC based xeno-free platform to assess the foreign body response against new biomaterials
基于 iPSC 的无异源平台,用于评估新生物材料的异物反应
- 批准号:
NC/Y000838/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
CAREER: Developing Ultrasound-Programmable 3D-Printed Biomaterials for Spatiotemporal Control of Gene Delivery
职业:开发用于基因传递时空控制的超声波可编程 3D 打印生物材料
- 批准号:
2339254 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Continuing Grant
FET: Small: Simulation-guided design of heterochiral DNA nanostructures for biomaterials applications
FET:小型:用于生物材料应用的异手性 DNA 纳米结构的模拟引导设计
- 批准号:
2312215 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Standard Grant
CAREER: Surfactant Proteins that Stabilize Biomolecular Condensates: From Biophysics to Biomaterials for Biomanufacturing
职业:稳定生物分子缩合物的表面活性剂蛋白:从生物物理学到生物制造的生物材料
- 批准号:
2238914 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Continuing Grant
CAREER: Modular Protein Origami to Build Genetically Programmable Biomaterials
职业:用模块化蛋白质折纸构建基因可编程生物材料
- 批准号:
2239927 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Continuing Grant
Antimicrobial biomaterials from bio-based feedstocks with novel feedstock supplementation strategies
采用新型原料补充策略的生物基原料制成的抗菌生物材料
- 批准号:
10063453 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Collaborative R&D
Mechanisms of accelerated calcification and structural degeneration of implantable biomaterials in pediatric cardiac surgery
小儿心脏手术中植入生物材料加速钙化和结构退化的机制
- 批准号:
10655959 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Semiconductor Biomaterials to Speed Bone Healing: A Bioengineering-Driven Approach
半导体生物材料加速骨骼愈合:生物工程驱动的方法
- 批准号:
10587508 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Pathophysiology and prevention of degeneration of heterograft biomaterials due to advanced glycation end products and serum protein infiltration
由于晚期糖基化终产物和血清蛋白浸润导致异种移植生物材料变性的病理生理学和预防
- 批准号:
10679910 - 财政年份:2023
- 资助金额:
-- - 项目类别:














{{item.name}}会员




